These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23229207)

  • 1. Hib vaccine: should it be introduced in the national immunization program?
    Taneja DK
    Indian J Public Health; 2012; 56(3):177-9. PubMed ID: 23229207
    [No Abstract]   [Full Text] [Related]  

  • 2. NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India.
    Subcommittee on Introduction of Hib Vaccine in Universal Immunization Program, National Technical Advisory Group on Immunization, India
    Indian Pediatr; 2009 Nov; 46(11):945-54. PubMed ID: 19955578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
    Eskola J
    J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae type b conjugate vaccines - a South African perspective.
    Visser A; Hoosen A
    Vaccine; 2012 Sep; 30 Suppl 3():C52-7. PubMed ID: 22939022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
    Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
    Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
    Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
    Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process.
    Garpenholt O; Fredlund H; Timpka T
    Scand J Public Health; 2001 Dec; 29(4):271-8. PubMed ID: 11775783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
    Gessner BD; Adegbola RA
    Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemophilus influenzae type b (Hib) Vaccination WHO position paper: July 2013-Recommendations.
    WHO
    Vaccine; 2013 Dec; 31(52):6168-9. PubMed ID: 24156921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hib vaccine in India: a case for universal immunization.
    Kumar A; Singh M; Thumburu KK; Jaiswal N; Kaur H; Sharma S; Agarwal A
    Vaccine; 2013 Aug; 31(37):3763-5. PubMed ID: 23830975
    [No Abstract]   [Full Text] [Related]  

  • 12. Rising incidence of Haemophilus influenzae type b disease in England and Wales indicates a need for a second catch-up vaccination campaign.
    Trotter CL; Ramsay ME; Slack MP
    Commun Dis Public Health; 2003 Apr; 6(1):55-8. PubMed ID: 12736974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b vaccine in Papua New Guinea: what can we expect, and how should we determine priority for child health interventions?
    Duke T
    P N G Med J; 1999; 42(1-2):1-4. PubMed ID: 11061000
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
    Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
    Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive infections caused by haemophilus influenzae serotypes in twelve Canadian IMPACT centers, 1996-2001.
    McConnell A; Tan B; Scheifele D; Halperin S; Vaudry W; Law B; Embree J;
    Pediatr Infect Dis J; 2007 Nov; 26(11):1025-31. PubMed ID: 17984810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease.
    Kilgore PE; Nyambat B
    J Health Popul Nutr; 2004 Sep; 22(3):246-56. PubMed ID: 15609777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The introduction of Haemophilus influenzae type b immunization into the United Kingdom: practical steps to assure success.
    Salisbury DM
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S136-9. PubMed ID: 9781747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction of Hib containing pentavalent vaccine in national immunization program of India: the concerns and the reality!
    Vashishtha VM
    Indian Pediatr; 2009 Sep; 46(9):781-2. PubMed ID: 19812422
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
    Ribeiro GS; Lima JB; Reis JN; Gouveia EL; Cordeiro SM; Lobo TS; Pinheiro RM; Ribeiro CT; Neves AB; Salgado K; Silva HR; Reis MG; Ko AI
    Vaccine; 2007 May; 25(22):4420-8. PubMed ID: 17449150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hib returns.
    Edwards A
    Minn Med; 2009 Mar; 92(3):35-6. PubMed ID: 19400384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.